Bhaven N. Sampat

Columbia University - Mailman School of Public Health

Assistant Professor

600 West 168th St. 6th Floor

New York, NY 10032

United States

SCHOLARLY PAPERS

25

DOWNLOADS
Rank 3,109

SSRN RANKINGS

Top 3,109

in Total Papers Downloads

9,942

CITATIONS
Rank 5,789

SSRN RANKINGS

Top 5,789

in Total Papers Citations

88

Scholarly Papers (25)

1.

What to do About Bad Patents

Regulation, Vol. 28, No. 4, pp. 10-13, Winter 2005-2006
Number of pages: 3 Posted: 13 Dec 2005
Mark A. Lemley, Douglas Lichtman and Bhaven N. Sampat
Stanford Law School, University of California, Los Angeles (UCLA) - School of Law and Columbia University - Mailman School of Public Health
Downloads 1,893 (5,783)
Citation 10

Abstract:

patent law, patent reform, patent, post-grant, gold-plate

2.

Do Applicant Patent Citations Matter?

7th Annual Conference on Empirical Legal Studies Paper, Stanford Law and Economics Olin Working Paper No. 401, Stanford Public Law Working Paper No. 1656568
Number of pages: 11 Posted: 10 Aug 2010 Last Revised: 07 Mar 2015
University of Richmond School of Law, Stanford Law School and Columbia University - Mailman School of Public Health
Downloads 1,319 (10,048)
Citation 3

Abstract:

Patent, Intellectual Property, Examiner, Inequitable Conduct, Presumption of Validity, Empirical, Prior Art, Patent Prosecution

3.
Downloads 1,063 ( 15,890)
Citation 4

When Do Generics Challenge Drug Patents?

Journal of Empirical Legal Studies, 2011, 5th Annual Conference on Empirical Legal Studies Paper, Columbia Law and Economics Working Paper No. 379
Number of pages: 58 Posted: 15 Jul 2010 Last Revised: 20 Feb 2014
C. Scott Hemphill and Bhaven N. Sampat
New York University School of Law and Columbia University - Mailman School of Public Health
Downloads 1,059 (15,691)
Citation 4

Abstract:

drugs, FDA, Hatch-Waxman, innovation, market entry, Paragraph IV challenge, patents, pharmaceuticals, R&D

When Do Generics Challenge Drug Patents?

Journal of Empirical Legal Studies, Vol. 8, Issue 4, pp. 613-649, 2011
Number of pages: 37 Posted: 29 Oct 2011
C. Scott Hemphill and Bhaven N. Sampat
New York University School of Law and Columbia University - Mailman School of Public Health
Downloads 4 (554,158)
Citation 4
  • Add to Cart

Abstract:

4.

Evergreening, Patent Challenges, and Effective Market Life in Pharmaceuticals

Journal of Health Economics, Vol. 31, 2012, Columbia Law and Economics Working Paper No. 399
Number of pages: 47 Posted: 05 May 2011 Last Revised: 28 Jul 2013
C. Scott Hemphill and Bhaven N. Sampat
New York University School of Law and Columbia University - Mailman School of Public Health
Downloads 902 (15,867)
Citation 4

Abstract:

Drugs, FDA, Innovation, Patents, Pharmaceuticals, R&D, Hatch-Waxman

5.

Examining Patent Examination

Stanford Technology Law Review, Vol. 2010, p. 2, 2010, Stanford Public Law Working Paper No. 1485011
Number of pages: 20 Posted: 08 Oct 2009 Last Revised: 06 Feb 2011
Bhaven N. Sampat and Mark A. Lemley
Columbia University - Mailman School of Public Health and Stanford Law School
Downloads 800 (21,208)
Citation 8

Abstract:

6.

Is the Patent Office a Rubber Stamp?

Emory Law Journal, Vol. 58, p. 181, 2008, Stanford Public Law Working Paper No. 999098, 2nd Annual Conference on Empirical Legal Studies Paper
Number of pages: 28 Posted: 09 Jul 2007 Last Revised: 06 Feb 2011
Mark A. Lemley and Bhaven N. Sampat
Stanford Law School and Columbia University - Mailman School of Public Health
Downloads 708 (24,460)
Citation 9

Abstract:

patent, patents, USPTO, intellectual property

7.

Examiner Characteristics and Patent Office Outcomes

Stanford Law and Economics Olin Working Paper No. 369
Number of pages: 11 Posted: 19 Jan 2009 Last Revised: 20 Aug 2012
Mark A. Lemley and Bhaven N. Sampat
Stanford Law School and Columbia University - Mailman School of Public Health
Downloads 633 (29,974)
Citation 2

Abstract:

8.

University Software Ownership and Litigation: A First Examination

Duke Law School Legal Studies Paper No. 160, Duke Science, Technology & Innovation Paper No. 20
Number of pages: 52 Posted: 26 Jun 2007 Last Revised: 14 May 2014
Arti K. Rai, John R. Allison and Bhaven N. Sampat
Duke University School of Law, University of Texas - McCombs School of Business and Columbia University - Mailman School of Public Health
Downloads 553 (38,858)
Citation 1

Abstract:

9.

Can Private Money Buy Public Science? Disease Group Lobbying and Federal Funding for Biomedical Research

Forthcoming in Management Science
Number of pages: 47 Posted: 23 Nov 2011 Last Revised: 08 Jan 2015
Deepak Hegde and Bhaven N. Sampat
New York University (NYU) - Leonard N. Stern School of Business and Columbia University - Mailman School of Public Health
Downloads 351 (55,213)

Abstract:

Lobbying, Special Interest Groups, National Institutes of Health, R&D

10.

Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of 'Secondary' Pharmaceutical Patents

PLOS ONE, December 2012, Volume 7, Issue 12, Yale Law School, Public Law Working Paper No. 271, Yale Law & Economics Research Paper No. 462
Number of pages: 11 Posted: 20 Dec 2012 Last Revised: 08 Jan 2013
Amy Kapczynski, Chan Park and Bhaven N. Sampat
Yale University - Law School, Medicines Patent Pool and Columbia University - Mailman School of Public Health
Downloads 195 (107,847)

Abstract:

patents, pharmaceuticals, innovation, intellectual property, secondary patents, international intellectual property law

11.

Making Sense of Institutions as a Factor Shaping Economic Performance (Spanish Version)

Revista de Economía Institucional, Vol. 3, No. 5, Second Semester 2001,
Number of pages: 37 Posted: 11 Aug 2006
Richard R. Nelson and Bhaven N. Sampat
Columbia University - School of International & Public Affairs (SIPA) and Columbia University - Mailman School of Public Health
Downloads 174 (124,992)
Citation 29

Abstract:

institutions, economic growth, rutines, social technologies, physical technologies

12.

Applicant and Examiner Citations in US Patents: An Overview and Analysis

Harvard Business School Strategy Unit Working Paper No. 09-016
Number of pages: 43 Posted: 25 Sep 2008
Juan Alcacer, Michelle Gittelman and Bhaven N. Sampat
Harvard University - Strategy Unit, Rutgers, The State University of New Jersey - Rutgers University, Newark and Columbia University - Mailman School of Public Health
Downloads 101 (211,257)
Citation 7

Abstract:

Technology, patents, patent examiners, prior art, citations

13.

Accountability in Patenting of Federally Funded Research

Nature Biotechnology, Vol. 30, No. 10, October 2012
Number of pages: 4 Posted: 05 Dec 2012
Arti K. Rai and Bhaven N. Sampat
Duke University School of Law and Columbia University - Mailman School of Public Health
Downloads 70 (229,112)

Abstract:

patents, Bayh-Dole, universities

14.

Serendipity

Number of pages: 38 Posted: 06 Jan 2015
Bhaven N. Sampat
Columbia University - Mailman School of Public Health
Downloads 54 (219,959)

Abstract:

serendipity, medical reseach funding, NIH

15.

Examiner Citations, Applicant Citations, and the Private Value of Patents

Economics Letters, Vol. 105, No. 3, 2009
Number of pages: 9 Posted: 12 Apr 2011 Last Revised: 03 Jan 2015
Deepak Hegde and Bhaven N. Sampat
New York University (NYU) - Leonard N. Stern School of Business and Columbia University - Mailman School of Public Health
Downloads 33 (311,158)
Citation 8

Abstract:

16.

The Diffusion of Scientific Knowledge Across Time and Space: Evidence from Professional Transitions for the Superstars of Medicine

NBER Working Paper No. w16683
Number of pages: 57 Posted: 18 Jan 2011 Last Revised: 03 Apr 2015
Pierre Azoulay, Joshua Graff Zivin and Bhaven N. Sampat
Massachusetts Institute of Technology (MIT) - Sloan School of Management, University of California, San Diego (UCSD) - Graduate School of International Relations and Pacific Studies (IRPS) and Columbia University - Mailman School of Public Health
Downloads 19 (443,922)
Citation 3

Abstract:

17.

Public R&D Investments and Private-Sector Patenting: Evidence from NIH Funding Rules

NBER Working Paper No. w20889
Number of pages: 113 Posted: 27 Jan 2015
Massachusetts Institute of Technology (MIT) - Sloan School of Management, University of California, San Diego (UCSD) - Graduate School of International Relations and Pacific Studies (IRPS), Harvard Business School and Columbia University - Mailman School of Public Health
Downloads 7 (475,191)
  • Add to Cart

Abstract:

18.

Trade Agreements, Patents, and Drug Prices: Continuing the Debate

Yale Law & Economics Research Paper No. 572
Number of pages: 10 Posted: 18 Mar 2017 Last Revised: 25 May 2017
Amy Kapczynski, Bhaven N. Sampat and Ken Shadlen
Yale University - Law School, Columbia University - Mailman School of Public Health and London School of Economics and Political Science
Downloads 0 (191,951)

Abstract:

pharmaceuticals, patents, trade agreements, TRIPS, TPP

19.

Secondary Pharmaceutical Patenting: A Global Perspective

NBER Working Paper No. w23114
Number of pages: 37 Posted: 30 Jan 2017
Bhaven N. Sampat and Ken Shadlen
Columbia University - Mailman School of Public Health and London School of Economics and Political Science
Downloads 0 (529,071)
  • Add to Cart

Abstract:

20.

How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome

NBER Working Paper No. w21666
Number of pages: 50 Posted: 26 Oct 2015 Last Revised: 30 Oct 2015
Bhaven N. Sampat and Heidi L. Williams
Columbia University - Mailman School of Public Health and MIT Department of Economics
Downloads 0 (212,609)

Abstract:

21.

The Bayh-Dole Act of 1980 and University Industry Technology Transer: A Model for Other OECD Governments?

University of Illinois at Urbana-Champaign's Academy for Entrepreneurial Leadership Historical Research Reference in Entrepreneurship
Posted: 09 Nov 2009
David C. Mowery and Bhaven N. Sampat
University of California, Berkeley - Haas School of Business and Columbia University - Mailman School of Public Health

Abstract:

OECD countries, R&D, Technology transfer, University-industry relations, Bayh-Dole Act of 1980, Licensing strategies, Patent law, Patents

22.

The Growth of Patenting and Licensing by U.S. Universities: An Assessment of the Effects of the Bayh-Dole Act of 1980

Research Policy, Vol. 30, pp. 99-119, 2001
Posted: 13 Dec 2006
University of California, Berkeley - Haas School of Business, Columbia University - School of International & Public Affairs (SIPA), Columbia University - Mailman School of Public Health and Questrom School of Business, Strategy and Innovation Department

Abstract:

Bayh-Dole Act, University Research, Technology Transfer, Patenting, Licensing

23.

Learning to Patent: Institutional Experience, Learning, and the Characteristics of University Patents after Bayh-Dole, 1980-1994

Management Science, Vol. 48, No. 1, pp. 73-89, 2002
Posted: 13 Dec 2006
David C. Mowery, Bhaven N. Sampat and Arvids A. Ziedonis
University of California, Berkeley - Haas School of Business, Columbia University - Mailman School of Public Health and Questrom School of Business, Strategy and Innovation Department

Abstract:

Patents, Universities, Technology Transfer, Learning

24.

Changes in University Patent Quality after the Bayh-Dole Act: A Re-Examination

International Journal of Industrial Organization, Vol. 21, No. 9, pp. 1371-1390, 2003
Posted: 13 Dec 2006
Bhaven N. Sampat, David C. Mowery and Arvids A. Ziedonis
Columbia University - Mailman School of Public Health, University of California, Berkeley - Haas School of Business and Questrom School of Business, Strategy and Innovation Department

Abstract:

O3

25.

Making Sense of Institutions as a Factor Shaping Economic Performance

Journal of Economic Behavior & Organization, Vol. 44, No. 1, January 2001
Posted: 07 Jun 2001
Richard R. Nelson and Bhaven N. Sampat
Columbia University - School of International & Public Affairs (SIPA) and Columbia University - Mailman School of Public Health

Abstract: